Emerging drugs for functional dyspepsia.
Newcastle, Australia. In Expert Opin Emerg Drugs, Jun 2015
Novel agents such as the motilin receptor agonist camicinal and the muscarinic M1 and M2 receptor antagonist acotiamide appear promising; however, the need for a safe and efficacious treatment remains largely unmet.
Gastrointestinal dysmotility: evidence and clinical management.
Adelaide, Australia. In Curr Opin Clin Nutr Metab Care, 2013
New treatment modalities for gastrointestinal dysfunction are being investigated and include small intestinal feeding, nonpharmacological options such as acupuncture, and drugs including novel motilin receptor agonists, and opioid antagonists.